Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma
Crossref DOI link: https://doi.org/10.1007/s11899-024-00740-z
Published Online: 2024-08-15
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pan, Darren
Richter, Joshua
Text and Data Mining valid from 2024-08-15
Version of Record valid from 2024-08-15
Article History
Accepted: 31 July 2024
First Online: 15 August 2024
Declarations
:
: D.P has received honoraria from Sanofi.